Leukemic Stem Cells and Hematological Malignancies
International Journal of Molecular Sciences · 17.06.2024 · 25 (12) · 6639
DOI: 10.3390/ijms25126639 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.06.2024. Verfasst von Hee-Seon Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Convergence Medicine, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Neoplastic Stem Cells. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, Ministry of Trade, Industry and Energy, Ministry of Health & Welfare, Ministry of Food and Drug Safety, the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education and Ministry of Health & Welfare, Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education and Ministry of Health & Welfare.
Abstract (Originalsprache)
The association between leukemic stem cells (LSCs) and leukemia development has been widely established in the context of genetic alterations, epigenetic pathways, and signaling pathway regulation. Hematopoietic stem cells are at the top of the bone marrow hierarchy and can self-renew and progressively generate blood and immune cells. The microenvironment, niche cells, and complex signaling pathways that regulate them acquire genetic mutations and epigenetic alterations due to aging, a chronic inflammatory environment, stress, and cancer, resulting in hematopoietic stem cell dysregulation and the production of abnormal blood and immune cells, leading to hematological malignancies and blood cancer. Cells that acquire these mutations grow at a faster rate than other cells and induce clone expansion. Excessive growth leads to the development of blood cancers. Standard therapy targets blast cells, which proliferate rapidly; however, LSCs that can induce disease recurrence remain after treatment, leading to recurrence and poor prognosis. To overcome these limitations, researchers have focused on the characteristics and signaling systems of LSCs and therapies that target them to block LSCs. This review aims to provide a comprehensive understanding of the types of hematopoietic malignancies, the characteristics of leukemic stem cells that cause them, the mechanisms by which these cells acquire chemotherapy resistance, and the therapies targeting these mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Convergence Medicine, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
- School of Biomedical Convergence Engineering, Pusan National University, Yangsan 50612, Republic of Korea.
- Department of Anatomy, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
- Transplantation Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
ORCID-Profile: Hee-Seon Choi, Byoung Soo Kim, Sik Yoon, Dongjun Lee
Förderung
- Ministry of Science and ICT, Ministry of Trade, Industry and Energy, Ministry of Health & Welfare, Ministry of Food and Drug Safety
- the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education and Ministry of Health & Welfare
- Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education and Ministry of Health & Welfare
- Korean Cell-Based Artificial Blood Project
- Basic Science Research Program
Zitieren
APA
Choi, H. S., Kim, B. S., Yoon, S., Oh, S. O., & Lee, D. (2024). Leukemic Stem Cells and Hematological Malignancies. International Journal of Molecular Sciences, 25(12), 6639. https://doi.org/10.3390/ijms25126639
Vancouver
Choi HS, Kim BS, Yoon S, Oh SO, Lee D. Leukemic Stem Cells and Hematological Malignancies. International Journal of Molecular Sciences. 2024;25(12):6639. doi:10.3390/ijms25126639
BibTeX
@article{Choi2024,
author = {Choi, Hee-Seon and Kim, Byoung Soo and Yoon, Sik and Oh, Sae-Ock and Lee, Dongjun},
title = {Leukemic Stem Cells and Hematological Malignancies},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {12},
pages = {6639},
doi = {10.3390/ijms25126639}
}
EUVIMED